Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Aadi Bioscience (AADI) has provided an update.
Loretta Itri, M.D., is stepping down as Chief Medical Officer but will receive a generous severance package and maintain a consulting role with her former company. Neil Desai, Ph.D., also plans to leave his role as Executive Chairman, with a severance in line with his agreement. Both will continue their involvement with the company, Itri through consulting and Desai as a board member, allowing them to retain their equity awards. This move could signal strategic shifts or a refresh in leadership, offering potential impacts on the company’s direction and stock performance.
For a thorough assessment of AADI stock, go to TipRanks’ Stock Analysis page.
